StimCardio Medical, Inc.
PrivateLast Round
Series A
Oct 29, 2026
Total Funding Raised
$30M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
StimCardio Medical, Inc. operates in Healthcare & Life Sciences and is based in Los Angeles, California. Its latest recorded funding round was a Series A round in October 2026.
StimCardio Medical, Inc. is a clinical-stage medical device company that develops non-invasive, wearable neuromodulation technologies for the treatment of cardiac rhythm disorders, beginning with atrial fibrillation.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
StimCardio Medical, Inc. Comparables
Compare StimCardio Medical, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CardiaCare | 84% | |
| Johnson & Johnson | 68% | |
| BIOTRONIK | 65% |
For institutional investors. Book with your work email.
StimCardio Medical, Inc. Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
StimCardio Medical, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Metis MedTech | Series A |
| Harvard Business School Alumni Angels of Greater New York | Series A |
| Catalyst Health Ventures | Series A |
| Ground Effect Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 29, 2026
$25M round led by Metis MedTech.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingOct 29, 2026
StimCardio Medical Inc. is developing Rhyvive, an investigational therapeutic wearable that delivers wrist stimulation to support post-ablation care; the company plans the NeuroPulse 2 multicenter pivotal study and preparation for an FDA De Novo submission, while the device has no regulatory clearance or approval and is unavailable for sale in California on Oct 29th '26.
- attends_eventOct 29, 2026
StimCardio Medical Inc. presents its NeuroPulse 1 pilot study as a late-breaking clinical trial at HRX Live 2026.
- receives_financingOct 29, 2026
On Oct 29th '26 in California, StimCardio Medical Inc. closes an oversubscribed $30M Series A financing led by John Slump’s family office, Metis Medtech, with participation from Catalyst Health Ventures and other investors to fund its planned NeuroPulse 2 pivotal study and prepare a De Novo FDA submission.
- is_developingSep 20, 2026
StimCardio Medical Inc. is developing Rhyvive(TM), an investigational, physician-prescribed, wrist-worn device designed as a non-invasive treatment adjunct to AF ablation, with a closed-loop system that delivers personalized neuromodulation informed by continuous physiological sensing under physician oversight.
For institutional investors. Book with your work email.
StimCardio Medical, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about StimCardio Medical, Inc.'s valuation, stock price, and market status.
Is StimCardio Medical, Inc. a public or private company?
StimCardio Medical, Inc. is a private company.
What is the current stock price of StimCardio Medical, Inc.?
StimCardio Medical, Inc. is a private company, so its shares have no public market price. Caplight tracks StimCardio Medical, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is StimCardio Medical, Inc. worth (valuation)?
Valuation information for StimCardio Medical, Inc. is not publicly available.
Can I buy StimCardio Medical, Inc. stock?
StimCardio Medical, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was StimCardio Medical, Inc.'s last funding round?
StimCardio Medical, Inc.'s most recent funding round was Series A on October 29, 2026.
Who are the main investors in StimCardio Medical, Inc.?
Key investors in StimCardio Medical, Inc. include Metis MedTech.
Will StimCardio Medical, Inc. IPO soon?
No public IPO plans have been announced for StimCardio Medical, Inc..
How can I track StimCardio Medical, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in StimCardio Medical, Inc.'s shares on secondary markets.